IGFBP3 and breast carcinoma: It has been shown that IGFBP-3 inhibits the growth of the IGF-unresponsive Hs578 human breast cancer cell line [8,16] and enhances the effects of ceramide and paclitaxol-induced apoptosis directly [7,29].